BioMatrix Specialty Pharmacy Partners with The National Hemophilia Foundation and Audaire Health to Improve Care for Patients with Bleeding Disorders


BIOMATRIX SPECIALTY PHARMACY PARTNERS WITH THE NATIONAL HEMOPHILIA FOUNDATION AND AUDAIRE HEALTH TO IMPROVE CARE FOR PATIENTS WITH BLEEDING DISORDERS

Innovative Digital Platform Increases Transparency and Accountability for Patients and Providers

Media Contact: Tara Marchese
Corporate Director of Marketing
Tel: 954-908-7636
Email: tara.marchese@biomatrixsprx.com

FOR IMMEDIATE RELEASE
[DOWNLOAD PDF]

Weston, FL – December 3, 2018 – BioMatrix Specialty Pharmacy announced today participation in a pilot program with the National Hemophilia Foundation (NHF) and Audaire Health Inc (Audaire) focused on reducing administrative burden, increasing patient adherence, and lowering health care costs. Pilot participants include a small group of select pharmacies and Hemophilia Treatment Centers (HTCs) who will utilize Audaire’s innovative data tracking tool demonstrating how the system can reduce cost of care and improve outcomes.

Andrew Berg, CEO at Audaire asserts, “We are thrilled to announce our partnership with NHF and BioMatrix. It’s a pleasure to find two partners as dedicated to simplifying the patient experience as we are. Our goal was to find pharmacy partners who value transparency, accountability, and driving better patient outcomes. BioMatrix is most definitely that partner.”

The Audaire Platform allows patients to instantly record infusions by utilizing their smartphone (at home or on the go) or a small electronic device kept in the home. The HIPAA-compliant system offers treatment reminders and passive logging capabilities that instantly transmit infusions to the patient’s care team. This “real-time” reporting provides opportunities for early intervention, preventing unnecessary and costly emergency room visits and/or hospitalizations. The Audaire Platform is unique in comparison to other logging devices. The system provides a nearly passive data input solution designed to ease reporting burden for patients and pharmacy providers. By capturing multiple data points including prescription, dispensation, pharmacy/clinic touch points, reported bleeds and other medication administration information, the Audaire Platform provides more robust capabilities than current logging systems.

“NHF believes that following prescribed treatments is a key to lowering costs and improving quality of life for people with bleeding disorders,” said Val D. Bias, CEO of the National Hemophilia Foundation. “We hope this program can make a real difference in people’s lives.”

“BioMatrix has a history of leveraging unique digital health technology producing positive outcomes for patients and reducing healthcare costs,” BioMatrix Chief Clinical Officer Marc Stranz shares. “This program demonstrates our commitment to providing the tools and support that make managing a chronic condition easier.”

Data from the pilot will be evaluated to identify the number of meaningful interventions resulting in cost reductions and or avoidance, changes in patient adherence and reporting rates, and improvements in assay and inventory management processes. The program is limited to patients on service with providers participating in the pilot. Initial findings will be shared at relevant industry symposia in 2019.


About BioMatrix Specialty Pharmacy

BioMatrix specialty pharmacy offers comprehensive, nationwide specialty pharmacy services and digital health technology solutions for patients with chronic, difficult to treat conditions. Our growing family of companies unites leaders in the specialty pharmacy industry to improve health and empower patients to experience a higher quality of life. The current BioMatrix family of companies includes:, BiologicTx, Decillion Healthcare, Elwyn Pharmacy Group, Factor Support Network, Matrix Health, and Medex BioCare.

About the National Hemophilia Foundation

Established in 1948, National Hemophilia Foundation (NHF) is a national nonprofit patient advocacy organization dedicated to finding better treatments and cures for inheritable bleeding disorders and to preventing the complications of these disorders through education, advocacy and research. NHF is a leader in supporting innovative solutions to help people with bleeding disorders and their families manage their disorder and improve their quality of life.

About Audaire Health

Audaire Health Inc (Audaire) is a healthcare technology company that focuses on facilitating transparency and accountability between payer, provider, pharmacy and patient. On the front end, Audaire's patent pending platform allows patients to seamlessly log medication adherence and exacerbations in real time. On the back end, all stakeholders (payers, providers, pharmacies) have real time insight into patient behavior, physician behavior and pharmacy dispensations. The end result is more informed providers, better performing pharmacies, and better patient outcomes.

BioMatrix Announces 2018 Academic Scholarship Recipients


BIOMATRIX ANNOUNCES 2018 ACADEMIC SCHOLARSHIP RECIPIENTS

Program Honors Memory of Bleeding Disorder Community Members

Media Contact: Tara Marchese
Corporate Director of Marketing
Tel: 954-908-7636
Email: tara.marchese@biomatrixsprx.com

FOR IMMEDIATE RELEASE
[DOWNLOAD PDF]

Weston, FL – November 27, 2018 – In honor of Giving Tuesday, BioMatrix Specialty Pharmacy announced today the recipients of their 2018 Memorial Scholarship Program. Six $1,500 academic scholarships were awarded to deserving applicants. The program honors the memory of several individuals who impacted the bleeding disorder community in unique ways. BioMatrix partners with the Hemophilia Federation of America for administrative support and independent, third-party evaluation of applicants.

“BioMatrix firmly believes in empowering patients to become strong self-advocates and leaders in their communities,” Tara Marchese, Corporate Director of Marketing at BioMatrix shares. “Our scholarship program honors the legacy of those memorialized by lifting up the next generation of leaders.”

The 2018 reward recipients are pursuing a range of academic interests from medicine to religion.

BioMatrix Memorial Scholarship Winners

MILES COLE
Joe Holibaugh Memorial Scholarship Recipient
Sophomore, Princeton University
Major: Undeclared

Taking his bleeding disorder in stride, Miles never lets severe hemophilia stop him from achieving his dreams. Very athletic throughout his life, he competed internationally with the USA Junior National Water Polo Team. “I grew up believing that as long as I was diligent about my meds, hemophilia did not have to define or limit my activities.” Miles adamantly offers, “Take charge of your life to shape it how you want it to be.”

BMX-Miles.jpg

LENA COOK
Millie Gonzalez Memorial Scholarship Recipient
Sophomore, California State Polytechnic University
Major: Kinesiology

Growing up as a female with hemophilia, Lena encountered challenges related to her diagnosis. “I have been told it is not possible for me to have hemophilia,” she shares. Lena learned to advocate for herself and is determined to help others. She started a women’s support group at her local chapter, “It was a fantastic opportunity to share our stories. It reaffirmed my

commitment to finding effective treatments for myself and other women with bleeding disorders.”

BMX-Lena.jpg

CALEB CROTHER
Mike Hylton Memorial Scholarship Recipient
Freshman, Westmont College
Major: Religious Studies

Salutatorian of his high school, Caleb enters college with the same gusto for learning and achieving. In addition to academics, Caleb plays five musical instruments and is very involved in his local community. He has received numerous accolades for his academic accomplishments and volunteer efforts. He affirms, “Having a bleeding disorder has helped me realize that as much as your community helps you, you should go and help your community.”

JUSTIN NAJIMIAN
Tim Kennedy Memorial Scholarship Recipient
Freshman, Rutgers University
Major: Public Health

“I carry my hemophilia gene not as a burden, but as a torch that gives light to the memories of generations past and blazes the trail for a new generation of leaders.” Like his beloved grandfather, Justin has hemophilia. He plans to pursue a career in public

health. “Healthcare policy, social work, advocacy or non-profit work are all paths I can see myself taking. Through advocacy and outreach, I would aim to bring camaraderie and care to hemophiliacs across the board.”

BMX-Justin.jpg

ISAIAH REEVES
Mark Coats Memorial Scholarship Recipient
University of Iowa
Carver College of Medicine, Major: Medicine

Isaiah was greatly influenced by his childhood physicians who treated his hemophilia. Inspired by those who helped him, he is pursuing a doctoral degree to become a pediatric hematologist/oncologist. “As a doctor, I will use my personal experiences, abilities and knowledge to support and enrich the lives of children. I will seek to emulate physicians from my own life who have been so impactful in making me the person I am today.”

BMX-Isaiah.jpg

RACHEL WILE
Ron Niederman Memorial Scholarship Recipient
Junior, UCLA
Major: Integrative Biology and Physiology

Rachel grew up hearing stories of the challenges her family members faced living with severe hemophilia. The experiences of her father and her uncle inspired Rachel to pursue a career in medicine. She hopes to conduct research leading to advancements in care for people with hemophilia. She shares, “Through my ongoing education and training, I hope one day to have a positive impact on the lives of those with bleeding disorders in this country and throughout the world.”

BMX-Rachel.jpg

About BioMatrix Specialty Pharmacy

BioMatrix specialty pharmacy offers comprehensive, nationwide specialty pharmacy services and digital health technology solutions for patients with chronic, difficult to treat conditions. Our growing family of companies unites leaders in the specialty pharmacy industry to improve health and empower patients to experience a higher quality of life. The current BioMatrix family of companies includes:, BiologicTx, Decillion Healthcare, Elwyn Pharmacy Group, Factor Support Network, Matrix Health, and Medex BioCare.

Medex Biocare Earns Perfect Score In URAC Specialty Pharmacy Accreditation


MEDEX BIOCARE EARNS PERFECT SCORE IN URAC SPECIALTY PHARMACY ACCREDITATION

Fourth Member Of The BioMatrix Family Of Companies To Receive Perfect URAC Score

Media Contact: Tara Marchese
Corporate Director of Marketing
Tel: 954-908-7636
Email: tara.marchese@biomatrixsprx.com

FOR IMMEDIATE RELEASE
[DOWNLOAD PDF]

Weston, FL – October 2, 2018Medex BioCare, a member of the BioMatrix family of companies, proudly announced today that it has received a perfect score and earned URAC accreditation in specialty pharmacy services for its Bartlett, Tennessee facility. This accreditation marks the fourth perfect URAC assessment score for a BioMatrix company, and the second within the last 16 months. URAC is the independent leader in promoting healthcare quality through leadership, accreditation, measurement and innovation. By achieving this status, Medex BioCare has demonstrated a comprehensive commitment to quality care, improved processes, and better patient outcomes.

"Patient care is our top priority. Receiving a perfect score and obtaining URAC accreditation validates our commitment to exceptional patient care and the effort we put forth to ensure consistency and compliance throughout our organization", stated Nicholas Karalis, Chief Operating Officer at BioMatrix Specialty Pharmacy. "I am thrilled with the efforts of the team at Medex BioCare and look forward to expanding URAC accreditation to all BioMatrix pharmacies."

“It’s necessary for specialty pharmacies to provide a higher level of treatment for patients so desired outcomes are achieved. Medex BioCare shows a dedication to patient education and safety through the recognition of quality it received with URAC’s independent accreditation,” said URAC President and CEO Kylanne Green. “With URAC accreditation, people know that Medex BioCare strives to adhere to industry best practices.”

About Medex BioCare

Medex BioCare, a member of the BioMatrix family of companies, is a specialty pharmacy dedicated to providing therapies and support for people with chronic conditions such as

bleeding disorders, neurological and immunological disorders, solid organ transplants, hepatitis C, HIV, and more. We are committed to providing individualized, patient-focused services to promote better health through encouraging positive self-management and building a local network of support.

About BioMatrix Specialty Pharmacy

BioMatrix specialty pharmacy offers comprehensive, nationwide specialty pharmacy services and digital health technology solutions for patients with chronic, difficult to treat conditions. Our growing family of companies unites leaders in the specialty pharmacy industry to improve health and empower patients to experience a higher quality of life. The current BioMatrix family of companies includes:, BiologicTx, Decillion Healthcare, Elwyn Pharmacy Group, Factor Support Network, Matrix Health, and Medex BioCare.

BioMatrix Announces Sponsorship For “Blood Work” 2018


BIOMATRIX ANNOUNCES SPONSORSHIP FOR “BLOOD WORK” 2018

Project Features Artwork from the Bleeding Disorders Community

Media Contact: Tara Marchese
Corporate Director of Marketing
Tel: 954-908-7636
Email: tara.marchese@biomatrixsprx.com

FOR IMMEDIATE RELEASE
[DOWNLOAD PDF]

Weston, FL – September 13, 2018 – BioMatrix specialty pharmacy announced today their support for “Blood Work 2018.” Blood Work celebrates creative expression within the bleeding disorders community. Submissions from across the country will be displayed in an interactive gallery for thousands of attendees at the National Hemophilia Foundation’s annual bleeding disorder conference this October in Orlando, Florida. Celebrating the many shapes and forms of creativity, featured works include paintings, music, fashion, and more. In its fifth installment, Blood Work is organized by the National Hemophilia Foundation and FOLX – a nonprofit organization working to promote the inclusion, visibility, and empowerment of people with diverse backgrounds in the bleeding disorders community.

BioMatrix is a founding sponsor of the Blood Work program and is proud to continue another year of support. Corporate Director of Marketing Tara Marchese shares, “We’re pleased to partner again with the National Hemophilia Foundation and FOLX on the fifth installment of Blood Work. Every year we are amazed at the incredible creativity and talent on display. It is a powerful representation of what it’s like to live with a bleeding disorder through the patient’s eyes.” Review submission criteria and other instructions here.

About BioMatrix Specialty Pharmacy

BioMatrix specialty pharmacy offers comprehensive, nationwide specialty pharmacy services and digital health technology solutions for patients with chronic, difficult to treat conditions. Our growing family of companies unites leaders in the specialty pharmacy industry to improve health and empower patients to experience a higher quality of life. The current BioMatrix family of companies includes:, BiologicTx, Decillion Healthcare, Elwyn Pharmacy Group, Factor Support Network, Matrix Health, and Medex BioCare.

BioMatrix Specialty Pharmacy Selected As Authorized Provider Of Vonvendi


BIOMATRIX SPECIALTY PHARMACY SELECTED AS AUTHORIZED PROVIDER OF VONVENDI

Agreement Enhances BioMatrix Product Offering to VWD Community

Media Contact: Tara Marchese
Corporate Director of Marketing
Tel: 954-908-7636
Email: tara.marchese@biomatrixsprx.com

FOR IMMEDIATE RELEASE
[DOWNLOAD PDF]

Weston, FL – May 2, 2018 – BioMatrix Specialty Pharmacy announced today their selection as an authorized provider of Shire’s limited distribution drug, Vonvendi™ [von Willebrand factor (Recombinant)]. Vonvendi is the first recombinant product indicated for on-demand treatment and control of bleeding episodes in adults diagnosed with von Willebrand disease (VWD). Von Willebrand disease is the most common bleeding disorder, affecting up to 1% of the US population. The chronic condition is caused by missing or dysfunctional von Willebrand Factor (VWF), leading to frequent recurring bleeding episodes.

Vonvendi is infused intravenously to replace missing or dysfunctional VWF. It is the first product to offer recombinant von Willebrand factor (rVWF) independent of recombinant Factor VIII (rFVIII). Shire reports this allows for a more tailored, patient specific treatment approach. Phase 3 open-label clinical study data demonstrated 100% treatment success using Vonvendi to control bleeding episodes.

“As a specialty pharmacy with extensive experience helping people with bleeding disorders effectively manage their condition, we are pleased to partner with Shire to offer Vonvendi,” said BioMatrix Chief Clinical Officer Marc Stranz. “We are committed to connecting patients with the products, resources and support to live a healthier life.”

To refer your patients to BioMatrix for Vonvendi therapy, please contact the pharmacy directly at 877-337-3002, online, or by completing a patient referral form. To review prescribing and other Vonvendi product information visit http://www.vonvendi.com.  

About BioMatrix Specialty Pharmacy
BioMatrix Specialty Pharmacy offers comprehensive nationwide specialty pharmacy services and digital health technology solutions for a range of chronic health conditions including bleeding disorders, solid organ transplants, hepatitis C, HIV and more.  Our growing family of companies unites leaders in the specialty pharmacy industry to improve health and empower patients to experience a higher quality of life.  The current BioMatrix family of companies includes BiologicTx, Decillion Healthcare, Elwyn Pharmacy Group, Factor Support NetworkMatrix Health, and Medex Biocare.

BioMatrix Specialty Pharmacy Acquires Decillion Healthcare Extending Footprint In Midwestern States


BIOMATRIX SPECIALTY PHARMACY ACQUIRES DECILLION HEALTHCARE EXTENDING FOOTPRINT IN MIDWESTERN STATES

Second Acquisition Expands BioMatrix Therapeutic Expertise And Limited Distribution Access

Media Contact: Tara Marchese
Corporate Director of Marketing
Tel: 954-908-7636
Email: tara.marchese@biomatrixsprx.com

DECILLION_BMX_LOGO.jpg

FOR IMMEDIATE RELEASE
[DOWNLOAD PDF]

Weston, FL – April 2, 2018 BioMatrix Specialty Pharmacy announced that it has acquired Decillion Healthcare, near Columbus, Ohio effective March 13, 2018.  Decillion provides individualized pharmacy and clinical support services for patients with chronic, difficult to treat conditions in neurology, oncology, gastroenterology, immunology, rheumatology and more. Decillion also provides infusion services from their wholly-owned ambulatory infusion center in Dublin, Ohio. The pharmacy is accredited by the Joint Commission and is a member organization of the NHIA Standards for Ethical Practice.

Resulting from the acquisition, BioMatrix enhances its capabilities in neurology, oncology and limited distribution drugs, while also establishing a bricks and mortar location in Ohio. The acquisition expands the BioMatrix footprint to twelve (12) specialty pharmacy locations nationwide, serving over 1,700 patients across a range of therapeutic categories.

“Decillion’s commitment to individualized patient care makes them a great addition to the BioMatrix family of companies,” said Bruce Greenberg, CEO at BioMatrix. “We are excited to expand our services further in the neurology, oncology and limited distribution drug categories, bringing our proven model of care to patients who need it the most.” 

“We are extremely excited to join BioMatrix,” stated Kenneth Ford, Owner and Chief Strategy Officer, Decillion Healthcare. “Our combined experience and dedication to individualized service will bring synergies allowing us to affect positive outcomes for the patients and communities we serve.”

About BioMatrix Specialty Pharmacy
BioMatrix Specialty Pharmacy offers comprehensive nationwide specialty pharmacy services and digital health technology solutions for a range of chronic health conditions including bleeding disorders, solid organ transplants, hepatitis C, HIV and more.  Our growing family of companies unites leaders in the specialty pharmacy industry to improve health and empower patients to experience a higher quality of life.  The current BioMatrix family of companies includes BiologicTx, Elwyn Pharmacy Group, Factor Support Network, Matrix Health, and Medex Biocare

Factor Support Network Earns Perfect Score In Urac Specialty Pharmacy Accreditation


FACTOR SUPPORT NETWORK EARNS PERFECT SCORE IN URAC SPECIALTY PHARMACY ACCREDITATION

Second Member Of The BioMatrix Family Of Companies To Receive Perfect URAC Score Within Last 12 Months

Media Contact: Tara Marchese
Corporate Director of Marketing
Tel: 954-908-7636
Email: tara.marchese@biomatrixsprx.com

FOR IMMEDIATE RELEASE
[DOWNLOAD PDF]

Weston, FL – March 26, 2018Factor Support Network, a member of the BioMatrix family of companies, proudly announced today that it has received a 100% URAC Application Score with zero deficiencies for specialty pharmacy at its Camarillo, CA location.  This reaccreditation marks the third perfect URAC assessment score for a BioMatrix company, and the second within the last 12 months.  URAC is the independent leader in promoting healthcare quality through leadership, accreditation, measurement and innovation.  Through reaccreditation, Factor Support Network has demonstrated a commitment to quality services, clinical expertise, and unsurpassed patient care.

“As a BioMatrix company, Factor Support Network is committed to providing pharmacy and support services helping patients achieve better health. URAC accreditation validates this commitment and represents our dedication to meeting and exceeding industry standards,” stated Bruce Greenberg, CEO at BioMatrix. "We applaud Factor Support Network on their achievement." 

“It’s necessary for specialty pharmacies to provide a higher level of treatment for patients so desired outcomes are achieved.  Factor Support Network shows a dedication to patient education and safety through the recognition of quality it received with URAC’s independent accreditation,” said URAC President and CEO Kylanne Green.  “With URAC accreditation, people know that Factor Support Network strives to adhere to industry best practices.”

About Factor Support Network
Factor Support Network, a member of the BioMatrix family of companies, was founded in 1994 by families who were affected with chronic healthcare challenges with the goal to meet the diverse needs of families and persons facing lifelong illnesses such as hemophilia and von Willebrand Disease.  We are committed to providing individualized, patient-focused services to people with bleeding disorders and other chronic conditions, nationwide.   Our services promote better health through encouraging positive self-management and building a local network of support.

About BioMatrix SpRx
BioMatrix SpRx offers comprehensive nationwide specialty pharmacy services and digital health technology solutions for a range of chronic health conditions including bleeding disorders, solid organ transplants, hepatitis C, HIV and more.  Our growing family of companies unites leaders in the specialty pharmacy industry to improve health and empower patients to experience a higher quality of life.  The current BioMatrix family of companies includes BiologicTx, Elwyn Pharmacy Group, Factor Support Network, Matrix Health, and Medex Biocare

About URAC
Founded in 1990, URAC is the independent leader in promoting healthcare quality through leadership, accreditation, measurement and innovation.  URAC is a nonprofit organization using evidence-based measures and developing standards through inclusive engagement with a range of stakeholders committed to improving the quality of healthcare.  Our portfolio of accreditation and certification programs span the healthcare industry, addressing healthcare management, healthcare operations, health plans, pharmacies, telehealth providers, physician practices, and more.  URAC accreditation is a symbol of excellence for organizations to showcase their validated commitment to quality and accountability.

BioMatrix SpRx Selected as Authorized Provider of Hemlibra


BIOMATRIX SPRX SELECTED AS AUTHORIZED PROVIDER OF HEMLIBRA

First New Product for Hemophilia Inhibitor Patients in Nearly 20 Years

Media Contact: Tara Marchese
Corporate Director of Marketing
Tel: 954-908-7636
Email: tara.marchese@biomatrixsprx.com

FOR IMMEDIATE RELEASE
[DOWNLOAD PDF]

Weston, FL – December 14, 2017 – BioMatrix SpRx today announced they have been selected as an authorized specialty pharmacy provider of Genentech’s new drug, Hemlibra (emicizumab-kxwh). The product is indicated for pediatric and adult patients who have hemophilia A with inhibitors.

Receiving Breakthrough Therapy Designation by the FDA in 2015, Hemlibra is the first self-administered, subcutaneous therapy for hemophilia. Data from ongoing clinical studies indicates once weekly injections substantially reduce bleed rates. To review information regarding Hemlibra, including the full list of authorized providers, visit the Genentech Hemlibra webpage. www.hemlibra.com  

Chief Clinical Officer David McCormick shares, “We are thrilled to partner with Genentech to offer Hemlibra. We have a long history of supporting patients with inhibitors and understand the unique challenges this community faces. We have witnessed the quality of life improvements this drug can provide, and are so proud to play our role in helping patients experience better health.”

To refer your patients to BioMatrix for Hemlibra therapy, please contact the pharmacy directly at 877-337-3002, online, or by completing a patient referral form.  

About BioMatrix SpRx
BioMatrix SpRx, a portfolio company of Acon Investments and Triton Pacific Capital Partners, LLC., offers comprehensive nationwide specialty pharmacy services and digital health technology solutions for a range of chronic health conditions.  Our growing family of companies unites leaders in the specialty pharmacy industry to improve health and empower patients to experience a higher quality of life.  The current BioMatrix family of companies includes Matrix Health Group, Factor Support Network, Medex BioCare, BiologicTx, and Elwyn Pharmacy Group.

BioMatrix Family of Companies Expands with Acquisition of Elwyn Pharmacy Group


Purchase Doubles Company Size And Adds Therapeutic Categories To Portfolio Of Services

Weston, FL – November 8, 2017BioMatrix SpRx, a growing leader in the specialty pharmacy industry, today announced the acquisition of Elwyn Pharmacy Group in Garnet Valley, Pennsylvania, 30 miles southwest of Philadelphia.

BioMatrix offers comprehensive nationwide specialty pharmacy services and digital health technology solutions for a range of chronic health conditions. The growing family of companies unites leaders in the specialty pharmacy industry to improve health and empower patients to experience a higher quality of life. BioMatrix excels in providing services for hemophilia and bleeding disorders, transplant therapy, IVIg and specialty care, and digital health technology.

Elwyn Pharmacy Group provides medications and supportive services for patients living with hard to treat disease states with the goal of achieving optimal patient outcomes. This is realized through compliance and individualized therapy management in an environment that maximizes patient satisfaction and adherence. Elwyn’s expertise in neurological and auto-immune disorders, fertility, oncology, and other chronic conditions has made them a leader in the specialty pharmacy industry.

As a result of this transaction, BioMatrix has expanded their services into complementary therapeutic categories requiring the same high-touch services they are accustomed to providing. BioMatrix’s national footprint increases to 11 pharmacy locations, nationwide, in key metropolitan locations. Elwyn joins the rapidly growing family of companies that comprise

BioMatrix including Matrix Health Group, Factor Support Network, Medex BioCare, and BiologicTx.

“The acquisition of Elwyn Pharmacy Group complements our strategy of bringing together leaders in the specialty pharmacy industry to provide comprehensive, compassionate care to patients living with complex, chronic diseases, “stated Bruce Greenberg, Chief Executive Officer, BioMatrix SpRx. “We are pleased to welcome Elwyn and their experienced staff to the BioMatrix family.”

“BioMatrix and Elwyn share very similar values. The success of both companies is rooted in our collaborative, compassionate patient-centered approach,” stated Nicholas Karalis, Chief Executive Officer, Elwyn Pharmacy Group. “Together, we expand our ability to provide a high level of individualized, focused care to patients living with a chronic condition. We are extremely excited to be part of this larger organization.”

Additional information on BioMatrix and Elwyn can be found at www.biomatrixsprx.com and www.elwynspecialtycare.com, respectively.

About BioMatrix SpRx

BioMatrix SpRx, a portfolio company of Acon Investments and Triton Pacific Capital Partners, LLC., offers comprehensive nationwide specialty pharmacy services and digital health technology solutions for a range of chronic health conditions. Our growing family of companies unites leaders in the specialty pharmacy industry to improve health and empower patients to experience a higher quality of life. The current BioMatrix family of companies includes Matrix Health Group, Factor Support Network, Medex BioCare, BiologicTx.

About Elwyn Pharmacy Group

Elwyn Pharmacy Group provides a complete range of specialty pharmacy and infusion services. We treat a wide array of complex disease states such as Multiple Sclerosis, Hepatitis C and other GI related diseases, Oncology/Cancer, bleeding disorders, Rheumatoid Arthritis, Psoriasis and HIV. The Elwyn Pharmacy Group includes Elwyn Pharmacy, Glen Rock Medical Pharmacy, Elwyn Specialty Care, and Med Center Specialty Pharmacy.